• Antibody-drug conjugates
• Targeting platform – 'OptiLink'
• Light activated cancer therapy – 'ProstaLite'
• MRI contrast agents & imaging
• Photosensitiser innovations
• Additional products and applications

• Investment History & Strategy
• Partnering opportunities

• Press Releases
• News Items
• Scientific Publications

• Background
• Achievements
• The Team
• Sitemap

PhotoBiotics Achievements

• Filed 5 families of patents and significantly enhanced proprietary position with the grant of a US patent
  
  
• Identified a lead therapeutic product candidate, and a novel imaging agent so expanding its market opportunities
  
  
• Obtained reproducible ‘cure’ efficacy data in cancer models
  
  
• Obtained preliminary safety data, demonstrating absence of photosensitivity in PDT
  
  
• Improved manufacturing reproducibility and scale-up
  
  
• Received third party endorsement from cancer clinicians and BioWorld Today who cited PhotoBiotics as one of the 200 top companies ‘leading a new wave of biotechnology development’